C
PTEN icon

Cerebellum’s Patterson-UTI PTEN Stock Holding History

Cerebellum’s Portfolio PTEN Stock Details PTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-73,504
Closed -$1.69M – 543
2020
Q2 		$1.69M Buy
+73,504
New +$253K 1.2% 25
2019
Q2 		– Sell
-11,757
Closed -$165K – 500
2019
Q1 		$165K Sell
11,757
-13,879
-54% -$182K 0.14% 353
2018
Q4 		$265K Buy
25,636
+15,717
+158% +$232K 0.18% 49
2018
Q3 		$170K Hold
9,919
– – 0.27% 284
2018
Q2 		$179K Sell
9,919
-928
-9% -$18.6K 0.3% 86
2018
Q1 		$190K Sell
10,847
-62,657
-85% -$1.31M 0.24% 114
2017
Q4 		$1.69M Buy
+73,504
New +$1.52M 1.2% 25

Other funds holding PTEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cerebellum's PTEN Position: Q3 2020 in Review

Cerebellum sold out of Patterson-UTI (PTEN) in Q3 2020, closing a stake of 73,504 shares — an estimated $1.69M sold.

Cerebellum first reported a position in PTEN in Q4 2017 and held it in 7 quarters. The position peaked at $1.69M in Q2 2020. 225 funds tracked by Wall St. Rank hold PTEN as of Q3 2020.

  • Cerebellum reported no remaining Patterson-UTI position as of Q3 2020 after selling out during the quarter.
  • Cerebellum sold 73,504 Patterson-UTI shares in Q3 2020, an estimated $1.69M.
  • Cerebellum first reported a position in Patterson-UTI in Q4 2017 and held it in 7 quarters.
  • Cerebellum's Patterson-UTI position peaked at $1.69M in Q2 2020.
  • 225 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.